Richard Schlegel
#17,340
Most Influential Person Now
American scientist
Richard Schlegel's AcademicInfluence.com Rankings
Richard Schlegelphilosophy Degrees
Philosophy
#4820
World Rank
#7472
Historical Rank
#1344
USA Rank
Logic
#7532
World Rank
#9318
Historical Rank
#1153
USA Rank
Download Badge
Philosophy
Richard Schlegel's Degrees
- PhD Microbiology University of Maryland, College Park
- Doctorate Medicine University of Maryland, College Park
Why Is Richard Schlegel Influential?
(Suggest an Edit or Addition)According to Wikipedia, C. Richard Schlegel is an American scientist and professor. He was the Chair of the Department of Pathology at Georgetown University from 2000-2019 and is now the director of the Center for Cell Reprogramming at Georgetown. Conditionally Reprogrammed Cells technology.
Richard Schlegel's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells. (2012) (651)
- TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains (1990) (633)
- Inhibition of VSV binding and infectivity by phosphatidylserine: Is phosphatidylserine a VSV-binding site? (1983) (308)
- Transcriptional Activation of the Telomerase hTERT Gene by Human Papillomavirus Type 16 E6 Oncoprotein (2001) (290)
- Human keratinocytes are efficiently immortalized by a Rho kinase inhibitor. (2010) (268)
- The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein (1993) (265)
- Conditionally reprogrammed cells represent a stem-like state of adult epithelial cells (2012) (255)
- Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter (2003) (249)
- Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens (2017) (210)
- The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes. (1989) (209)
- The E5 transforming gene of bovine papillomavirus encodes a small, hydrophobic polypeptide. (1986) (199)
- Papilloma virus immortalized tracheal epithelial cells retain a well-differentiated phenotype. (1993) (184)
- Bovine papillomavirus E5 oncoprotein binds to the 16K component of vacuolar H+-ATPases (1991) (180)
- Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation (1996) (165)
- Amantadine and dansylcadaverine inhibit vesicular stomatitis virus uptake and receptor-mediated endocytosis of alpha 2-macroglobulin. (1982) (161)
- Use of reprogrammed cells to identify therapy for respiratory papillomatosis. (2012) (157)
- Activation of the canonical Wnt pathway during genital keratinocyte transformation: a model for cervical cancer progression. (2005) (157)
- Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene. (2005) (148)
- Immunization with a Pentameric L1 Fusion Protein Protects against Papillomavirus Infection (2001) (146)
- Koilocytosis: a cooperative interaction between the human papillomavirus E5 and E6 oncoproteins. (2008) (137)
- The BPV‐1 E5 protein, the 16 kDa membrane pore‐forming protein and the PDGF receptor exist in a complex that is dependent on hydrophobic transmembrane interactions. (1992) (133)
- Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo. (2005) (132)
- Expression of dominant negative Jun inhibits elevated AP-1 and NF-κB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes (1998) (131)
- The E5 oncoprotein of bovine papillomavirus is oriented asymmetrically in Golgi and plasma membranes. (1989) (130)
- Serum- and calcium-induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16 (1996) (123)
- The E5 gene of HPV-16 enhances keratinocyte immortalization by full-length DNA. (1996) (123)
- The human T-cell leukemia/lymphotropic virus type I p12I protein cooperates with the E5 oncoprotein of bovine papillomavirus in cell transformation and binds the 16-kilodalton subunit of the vacuolar H+ ATPase (1993) (123)
- The Human Papillomavirus Type 16 E6 and E7 Oncoproteins Dissociate Cellular Telomerase Activity from the Maintenance of Telomere Length* (1997) (122)
- HPV E6 protein interacts physically and functionally with the cellular telomerase complex (2009) (121)
- 44-amino-acid E5 transforming protein of bovine papillomavirus requires a hydrophobic core and specific carboxyl-terminal amino acids (1988) (119)
- The E6AP Ubiquitin Ligase Is Required for Transactivation of the hTERT Promoter by the Human Papillomavirus E6 Oncoprotein* (2005) (116)
- The E7 protein of human papillomavirus type 16 sensitizes primary human keratinocytes to apoptosis (1998) (115)
- Golgi Alkalinization by the Papillomavirus E5 Oncoprotein (2000) (114)
- Pharmacological Rescue of Conditionally Reprogrammed Cystic Fibrosis Bronchial Epithelial Cells (2017) (109)
- Radiation induces diffusible feeder cell factor(s) that cooperate with ROCK inhibitor to conditionally reprogram and immortalize epithelial cells. (2013) (102)
- Chemically induced premature mitosis: differential response in rodent and human cells and the relationship to cyclin B synthesis and p34cdc2/cyclin B complex formation. (1991) (101)
- Representative cDNA libraries and their utility in gene expression profiling. (1999) (99)
- Saturable binding sites for vesicular stomatitis virus on the surface of Vero cells (1982) (93)
- Simian Virus 40 Small Tumor Antigen Activates AKT and Telomerase and Induces Anchorage-Independent Growth of Human Epithelial Cells (2002) (91)
- Severe Papillomavirus Infection Progressing to Metastatic Squamous Cell Carcinoma in Bone Marrow-Transplanted X-Linked SCID Dogs (2006) (91)
- BRCA1 Interaction with Human Papillomavirus Oncoproteins* (2005) (89)
- Endoplasmic Reticulum-Localized Human Papillomavirus Type 16 E5 Protein Alters Endosomal pH but Not trans-Golgi pH (2005) (89)
- Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domain (1993) (88)
- HPV E7 contributes to the telomerase activity of immortalized and tumorigenic cells and augments E6-induced hTERT promoter function. (2008) (86)
- Codon optimization of the HPV-16 E5 gene enhances protein expression. (2003) (86)
- Genetic and biochemical definition of the bovine papillomavirus E5 transforming protein. (1987) (85)
- Inhibition of serum- and calcium-induced differentiation of human keratinocytes by HPV16 E6 oncoprotein: role of p53 inactivation. (1997) (82)
- DNA sequence of the HPV-16 E5 ORF and the structural conservation of its encoded protein. (1988) (81)
- The bovine papillomavirus type 1 E5 transforming protein specifically binds and activates the beta-type receptor for the platelet-derived growth factor but not other related tyrosine kinase-containing receptors to induce cellular transformation (1994) (80)
- Cellular alterations dependent upon the polyoma virus hr-t function: Separation of mitogenic from transforming capacities (1978) (80)
- Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma (2016) (80)
- Vacuolar H+-ATPase Mutants Transform Cells and Define a Binding Site for the Papillomavirus E5 Oncoprotein (*) (1995) (75)
- Receptor-mediated endocytosis in cultured fibroblasts: cryptic coated pits and the formation of receptosomes. (1981) (75)
- The E5 protein of HPV-6, but not HPV-16, associates efficiently with cellular growth factor receptors. (1994) (73)
- Expression of Dominant-negative Fas-associated Death Domain Blocks Human Keratinocyte Apoptosis and Vesication Induced by Sulfur Mustard* (2003) (70)
- Differences in transformation activity between HPV-18 and HPV-16 map to the viral LCR-E6-E7 region. (1991) (69)
- E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells. (2006) (69)
- The Human Papillomavirus Type 16 E5 Oncoprotein Inhibits Epidermal Growth Factor Trafficking Independently of Endosome Acidification (2010) (69)
- A glutamine residue in the membrane-associating domain of the bovine papillomavirus type 1 E5 oncoprotein mediates its binding to a transmembrane component of the vacuolar H(+)-ATPase (1992) (67)
- Cell-Restricted Immortalization by Human Papillomavirus Correlates with Telomerase Activation and Engagement of the hTERT Promoter by Myc (2008) (66)
- An epidermotropic canine papillomavirus with malignant potential contains an E5 gene and establishes a unique genus. (2007) (66)
- Elevation of cell cycle control proteins during spontaneous immortalization of human keratinocytes. (1993) (60)
- Beta-Catenin Accelerates Human Papilloma Virus Type-16 Mediated Cervical Carcinogenesis in Transgenic Mice (2011) (58)
- Membrane Orientation of the Human Papillomavirus Type 16 E5 Oncoprotein (2009) (57)
- The E5 oncoprotein target: A 16‐kDa channel‐forming protein with diverse functions (1991) (56)
- Downregulation of Bax mRNA expression and protein stability by the E6 protein of human papillomavirus 16. (2005) (54)
- Strigolactone analogues induce apoptosis through activation of p38 and the stress response pathway in cancer cell lines and in conditionally reprogramed primary prostate cancer cells. (2014) (54)
- Cotransfection of HPV-18 and v-fos DNA induces tumorigenicity of primary human keratinocytes. (1993) (53)
- HPV16 E6 oncoprotein inhibits apoptosis induced during serum-calcium differentiation of foreskin human keratinocytes. (1999) (53)
- Induction of cell transformation by mutated 16K vacuolar H+-atpase (ductin) is accompanied by down-regulation of gap junctional intercellular communication and translocation of connexin 43 in NIH3T3 cells (1998) (50)
- Conditionally reprogrammed normal and primary tumor prostate epithelial cells: a novel patient-derived cell model for studies of human prostate cancer (2016) (49)
- E5 oncoprotein transmembrane mutants dissociate fibroblast transforming activity from 16-kilodalton protein binding and platelet-derived growth factor receptor binding and phosphorylation (1996) (49)
- Conditional Reprogramming for Patient-Derived Cancer Models and Next-Generation Living Biobanks (2019) (48)
- Myc and Human Papillomavirus Type 16 E7 Genes Cooperate To Immortalize Human Keratinocytes (2007) (48)
- The E6 Oncoprotein from HPV16 Enhances the Canonical Wnt/β-Catenin Pathway in Skin Epidermis In Vivo (2011) (47)
- Mutation of the bovine papillomavirus E5 oncoprotein at amino acid 17 generates both high- and low-transforming variants (1994) (46)
- Elevated expression and activity of mitotic regulatory proteins in human papillomavirus-immortalized keratinocytes. (1994) (45)
- Cervical epithelial cells transduced with the papillomavirus E6/E7 oncogenes maintain stable levels of oncoprotein expression but exhibit progressive, major increases in hTERT gene expression and telomerase activity. (2002) (45)
- Mutational analysis of the beta-type platelet-derived growth factor receptor defines the site of interaction with the bovine papillomavirus type 1 E5 transforming protein (1995) (44)
- E5 oncoprotein retained in the endoplasmic reticulum/cis Golgi still induces PDGF receptor autophosphorylation but does not transform cells. (1995) (44)
- MYC regulates fatty acid metabolism through a multigenic program in claudin-low triple negative breast cancer (2020) (43)
- Breaking the in vitro alveolar type II cell proliferation barrier while retaining ion transport properties. (2014) (42)
- HPV16 E7 Protein and hTERT Proteins Defective for Telomere Maintenance Cooperate to Immortalize Human Keratinocytes (2013) (39)
- A multiplex preclinical model for adenoid cystic carcinoma of the salivary gland identifies regorafenib as a potential therapeutic drug (2017) (39)
- Differential effect of tumor necrosis factor on proliferation of primary human keratinocytes and cell lines containing human papillomavirus types 16 and 18 (1992) (38)
- Karyopherin beta3: a new cellular target for the HPV-16 E5 oncoprotein. (2008) (37)
- The induction of the p53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cells (2014) (37)
- HPV positive neuroendocrine cervical cancer cells are dependent on Myc but not E6/E7 viral oncogenes (2017) (35)
- The Canine Papillomavirus and Gamma HPV E7 Proteins Use an Alternative Domain to Bind and Destabilize the Retinoblastoma Protein (2010) (34)
- Insulin-like growth factor-binding protein 3 expression increases during immortalization of cervical keratinocytes by human papillomavirus type 16 E6 and E7 proteins. (2002) (34)
- Inhibition of serum- and calcium-induced terminal differentiation of human keratinocytes by HPV 16 E6: study of the association with p53 degradation, inhibition of p53 transactivation, and binding to E6BP. (2002) (34)
- Monensin blocks endocytosis of vesicular stomatitis virus. (1981) (32)
- Modulation of cell growth, p34cdc2 and cyclin A levels by SV-40 large T antigen. (1993) (32)
- Induction of apoptosis in human keratinocytes containing mutated p53 alleles and its inhibition by both the E6 and E7 oncoproteins. (1998) (32)
- E5 Oncoprotein Mutants Activate Phosphoinositide 3-Kinase Independently of Platelet-derived Growth Factor Receptor Activation* (2000) (31)
- Patient-derived conditionally reprogrammed cells maintain intra-tumor genetic heterogeneity (2018) (31)
- Immortalization and transformation of human mammary epithelial cells by a tumor-derived Myc mutant (2009) (31)
- ROCK inhibitor reduces Myc-induced apoptosis and mediates immortalization of human keratinocytes (2016) (30)
- HPV-16 E7 protein bypasses keratinocyte growth inhibition by serum and calcium. (1998) (30)
- Direct HPV E6/Myc interactions induce histone modifications, Pol II phosphorylation, and hTERT promoter activation (2017) (29)
- Are transforming properties of the bovine papillomavirus E5 protein shared by E5 from high-risk human papillomavirus type 16? (2005) (29)
- The HPV-16 E5 protein represses expression of stress pathway genes XBP-1 and COX-2 in genital keratinocytes. (2010) (28)
- Induction of apoptosis in human keratinocytes containing mutated p53 alleles and its inhibition by both the E6 and E7 oncoproteins (1998) (28)
- Conditionally Reprogrammed Normal and Transformed Mouse Mammary Epithelial Cells Display a Progenitor-Cell–Like Phenotype (2014) (28)
- The Transmembrane Domain of the E5 Oncoprotein Contains Functionally Discrete Helical Faces* (1999) (28)
- Viable adenovirus vaccine prototypes: high-level production of a papillomavirus capsid antigen from the major late transcriptional unit. (2005) (27)
- Transforming proteins of the papillomaviruses. (1994) (26)
- c-Src Activation by the E5 oncoprotein enables transformation independently of PDGF receptor activation (2002) (26)
- Characterization of HPV16 L1 loop domains in the formation of a type-specific, conformational epitope (2004) (26)
- Binding and internalization of α2-macroglobulin by cultured fibroblasts: Effects of monovalent ionophores (1982) (26)
- PROSPECTS FOR A VACCINE AGAINST HUMAN PAPILLOMAVIRUS (1995) (25)
- HPV-16 E6/7 Immortalization Sensitizes Human Keratinocytes to Ultraviolet B by Altering the Pathway from Caspase-8 to Caspase-9-dependent Apoptosis* (2002) (25)
- IGFBP-3, a Marker of Cellular Senescence, Is Overexpressed in Human Papillomavirus-Immortalized Cervical Cells and Enhances IGF-1-Induced Mitogenesis (2004) (25)
- The Human Papillomavirus Type 16 E5 Oncoprotein Translocates Calpactin I to the Perinuclear Region (2011) (24)
- Role of the nuclear receptor coactivator AIB1/SRC-3 in angiogenesis and wound healing. (2012) (24)
- Telomerase enzymatic component hTERT shortens long telomeres in human cells (2014) (24)
- Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis (2019) (24)
- A multimeric L2 vaccine for prevention of animal papillomavirus infections. (2011) (22)
- VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cells (2011) (21)
- Identification of H, K, and N-ras point mutations in stage IB cervical carcinoma. (1997) (21)
- Circulating Tumor Cells: Technologies and Their Clinical Potential in Cancer Metastasis (2021) (20)
- Quantitative Measurement of Human Papillomavirus Type 16 E5 Oncoprotein Levels in Epithelial Cell Lines by Mass Spectrometry (2012) (20)
- Thermoresponsive release of viable microfiltrated Circulating Tumor Cells (CTCs) for precision medicine applications. (2015) (20)
- Δ133p53α, a natural p53 isoform, contributes to conditional reprogramming and long-term proliferation of primary epithelial cells (2018) (19)
- Conditional cell reprogramming involves non-canonical β-catenin activation and mTOR-mediated inactivation of Akt (2017) (19)
- Reversible and irreversible inhibitors of clustering of alpha 2M in clathrin-coated pits on the surface of fibroblasts. (1982) (19)
- Genomic Sequence of Canine Papillomavirus 19 (2016) (19)
- Complete Genome Sequence of Canine Papillomavirus Type 10 (2012) (18)
- Quantifying the CDK inhibitor VMY-1-103’s activity and tissue levels in an in vivo tumor model by LC-MS/MS and by MRI (2012) (16)
- Complete Genome Sequence of Canine Papillomavirus Type 16 (2015) (16)
- Continuous culture of urine-derived bladder cancer cells for precision medicine (2019) (16)
- Fidelity of a PDX-CR model for bladder cancer. (2019) (15)
- High-throughput screening identifies candidate drugs for the treatment of recurrent respiratory papillomatosis (2019) (15)
- Long-term expansion of primary equine keratinocytes that maintain the ability to differentiate into stratified epidermis (2018) (14)
- The serine protease inhibitors TLCK and TPCK react with the RB-binding core of HPV-18 E7 protein and abolish its RB-binding capability. (1996) (14)
- The Canine Papillomavirus E5 Protein Signals from the Endoplasmic Reticulum (2009) (13)
- The serine protease inhibitors TLCK and TPCK inhibit the in vitro immortalization of primary human keratinocytes by HPV-18 DNA. (1996) (12)
- Complete Genome Sequence of Canine Papillomavirus Type 9 (2012) (12)
- Canine keratinocytes upregulate type I interferons and proinflammatory cytokines in response to poly(dA:dT) but not to canine papillomavirus. (2013) (12)
- Complete Genome Sequence of Canine Papillomavirus Virus Type 12 (2015) (11)
- Characterization of Rat Meibomian Gland Ion and Fluid Transport (2016) (11)
- Efficient Propagation of Circulating Tumor Cells: A First Step for Probing Tumor Metastasis (2020) (10)
- Complete Genome Sequence of Canine Papillomavirus Type 11 (2014) (9)
- The induction of the p 53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cells (2014) (8)
- Keratinocyte Antiviral Response to Poly(dA:dT) Stimulation and Papillomavirus Infection in a Canine Model of X-Linked Severe Combined Immunodeficiency (2014) (7)
- Involvement of Na+ and HCO 3− in receptor‐mediated endocytosis of α2‐macroglobulin, epidermal growth factor, and vesicular stomatitis virus (1982) (7)
- Murine neuroblastoma cell lines developed by conditional reprogramming preserve heterogeneous phenotypes observed in vivo (2019) (7)
- PD-L1 expression and CD8+ infiltration shows heterogeneity in juvenile recurrent respiratory papillomatosis. (2017) (7)
- Divergent Human Papillomavirus Associated with Recurrent Respiratory Papillomatosis with Lung Involvement (2013) (7)
- Papillomaviruses: Ciba Foundation Symposium 120 (1987) (6)
- Abstract 1569: Next generation cell line models: conditionally reprogrammed cells. (2013) (5)
- Keratinocytes immortalized by human papillomavirus-18 exhibit alterations dependent upon host genetic background and complexity of viral genes transfected. (1994) (5)
- Comparison of PV Conformational Epitopes Expressed by L1 Proteins in Mammalian (COS) and Insect (SF9) Cells (1994) (4)
- Probing the Function of Viral Fusion Proteins with Synthetic Peptides (1987) (3)
- HPV 16 E 6 / 7 immortalization sensitizes human keratinocytes to UVB by altering the pathway from caspase-8 to caspase-9-dependent apoptosis (2002) (3)
- Perspectives on the Functional Characterization and In Vitro Maintenance of Circulating Tumor Cells (2016) (3)
- NOTES TheE6andE7GenesoftheHumanPapillomavirus Type16 Together AreNecessary andSufficient forTransformation ofPrimary HumanKeratinocytes (1989) (2)
- Artemisinin and its Derivatives – Novel Treatment Options for HPV-infection and Cervical Dysplasia (2008) (2)
- In vitro photodynamic treatment of normal and human papilloma virus-transfected keratinocytes with photofrin II and red light. (1991) (2)
- Abstract 4256: Functional analysis for cancer precision medicine using patient-derived 2D and 3D cell models (2016) (2)
- Supplementary Information (SI) (2010) (2)
- Binding and internalization of alpha 2-microglobulin by cultured fibroblasts. Effects of monovalent ionophores. (1982) (1)
- Abstract B15: Patient-derived Pancreatic Adenocarcinoma cells: A new model system to define chemotherapy resistance mechanisms and to improve targeted personalized treatment (2016) (0)
- Abstract IA26: Conditionally Reprogrammed Cells (CRCs): A simple, two-component cell system for basic and clinical cancer research (2016) (0)
- Cervical stem cells: Isolation, characterization, and potential role in human papillomavirus (HPV)-induced cervical carcinogenesis (2006) (0)
- Abstract LB-112: The human papillomavirus type 16 E5 protein represses X-box binding protein 1 and cyclooxygenase-2 stress signaling in keratinocytes (2010) (0)
- Together Are Necessary and Sufficient for Transformation (0)
- Long-term expansion of primary equine keratinocytes that maintain the ability to differentiate into stratified epidermis (2018) (0)
- Novel Preclinical In Vitro and In Vivo Model Systems for Adenoid Cystic Carcinoma of Salivary Gland (2016) (0)
- Long-Term Culture of Canine Ocular Cells That Maintain Canine Papillomaviruses (2022) (0)
- The Human Papillomavirus Type 16 E5 Oncoprotein Inhibits Epidermal Growth Factor Trafficking Independently of Endosome Acidification (cid:1) (2010) (0)
- Patient-derived conditionally reprogrammed cells maintain intra-tumor genetic heterogeneity (2018) (0)
- AIB1 is a novel target of the high‐risk HPV E6 protein and a biomarker of cervical cancer progression (2022) (0)
- Abstract 812: Multiplatform modeling of pancreatic cancer using patient-derived cells: A new approach for defining drug resistance mechanisms (2017) (0)
- Abstract 1441: MYC expression promotes lipid metabolism and metabolic plasticity in human mammary epithelial cells (2018) (0)
- Use of artemisinin in the treatment of tumors formed by oncogenic viruses and for treating viral infections (2004) (0)
- Two conserved amino acids differentiate the biology of high‐risk and low‐risk HPV E5 proteins (2022) (0)
- Abstract 5138: New technique generates cell cultures from rare adenoid cystic carcinomas of the salivary gland (2015) (0)
- Abstract 585: A robust method for expanding patient-derived circulating tumor cellsex vivo (2021) (0)
- Abstract 4328: Beta-catenin accelerates human papillomavirus type16 -E7 mediated cervical carcinogenesis in transgenic mice (2011) (0)
- A multiplex preclinical model for adenoid cystic carcinoma of the salivary gland identifies regorafenib as a potential therapeutic drug (2017) (0)
- Using the Papillomavirus E6/E7 Genes to Generate Well-Differentiated Epithelial Cell Lines (1991) (0)
- Abstract 2402: The impact of genomic heterogeneity in colorectal carcinoma on therapy response - a study on monoclonal primary colon cultures (2016) (0)
- Abstract PR06: Conditional reprogramming is successful in generating patient-derived stable cell cultures from rare aggressive tumors (2016) (0)
- Abstract 5145: Y-27632 inhibits Myc-induced apoptosis and cooperates with Myc to immortalize human keratinocytes (2015) (0)
- Abstract A30: In vitro transformation of human primary epithelial cells by Myc (2015) (0)
- Zebrafish xenografts to isolate unique human breast cancer metastatic cell populations (2021) (0)
- Abstract CN03-02: Conditionally reprogrammed cells for personalized medicine. (2013) (0)
- 08:20: A Canine Model for Recurrent Respiratory Papillomatosis (2007) (0)
- MYC regulates fatty acid metabolism through a multigenic program in claudin-low triple negative breast cancer (2020) (0)
- Abstract LB-224: A novel model of pediatric spinal ependymoma using conditionally reprogrammed cells from a primary tumor demonstrates aberrant expression ofHMGA, HOX, MYCand other Wnt target genes (2017) (0)
- Patient-derived cell models for cancer precision medicine. (2016) (0)
- The E6 gene of HPV 16 is sufficient for colony formation in primary human keratinocytes (2007) (0)
- Overexpression of the telomerase holoenzyme induces EMT and tumorigenesis of HPV‐immortalized keratinocytes (2023) (0)
- Propagated Circulating Tumor Cells Uncover the Potential Role of NFκB, EMT, and TGFβ Signaling Pathways and COP1 in Metastasis (2023) (0)
- Propagated circulating tumor cells uncovers the role of NFκB and COP1 in metastasis (2022) (0)
- Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma (2016) (0)
- Abstract 2972: Conditionally reprogrammed cells (CRCs): A new model for cancer research and personalized medicine (2014) (0)
- Identifying drivers of breast cancer metastasis in progressively invasive subpopulations of zebrafish-xenografted MDA-MB-231 (2022) (0)
- Abstract 5777: Translation of HPV mediated immortalization to cancer precision medicine (2017) (0)
- Pulmonary Papillomatosis: HPV11 Mutation and Vorinostat Therapy (2012) (0)
- Abstract 5123: Establishing circulating tumor cell-derived xenografts following a period of in vitro culture (2022) (0)
- Δ133p53α, a natural p53 isoform, contributes to conditional reprogramming and long-term proliferation of primary epithelial cells (2018) (0)
This paper list is powered by the following services:
Other Resources About Richard Schlegel
What Schools Are Affiliated With Richard Schlegel?
Richard Schlegel is affiliated with the following schools:
